Regenxbio (NASDAQ:RGNX) is set to give its latest quarterly earnings report on Thursday, 2026-03-05. Here’s what investors need to know before the announcement.
Analysts estimate that Regenxbio will report an earnings per share (EPS) of $-0.91.
The announcement from Regenxbio is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Earnings Track Record
The company’s EPS beat by $0.13 in the last quarter, leading to a 0.36% increase in the share price on the following day.
Here’s a look at Regenxbio’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.33 | -1.08 | 0.49 | -1.08 |
| EPS Actual | -1.20 | -1.38 | 0.12 | -1.01 |
| Price Change % | 0.36 | -0.63 | 2.63 | 2.60 |
Regenxbio Share Price Analysis
Shares of Regenxbio were trading at $8.69 as of March 03. Over the last 52-week period, shares are up 42.09%. Given that these returns are generally positive, long-term shareholders are likely bullish going into …